Zydus Lifesciences Ltd has received the EIR report from the USFDA for the inspection conducted at the injectables manufacturing facility at Zydus Biotech Park located at Changodar, Ahmedabad from 5th to 13th June, 2023. The inspection was a cGMP Inspection and had ended with NIL observations.
Shares of Cadila Healthcare Limited was last trading in BSE at Rs. 627.65 as compared to the previous close of Rs. 628.70. The total number of shares traded during the day was 70941 in over 3015 trades.
The stock hit an intraday high of Rs. 642.85 and intraday low of 624.15. The net turnover during the day was Rs. 44809498.00.